Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology

Nurix Therapeutics

Brisbane (CA)

On-site

USD 127,000 - 143,000

Full time

14 days+
Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

Nurix Therapeutics is seeking a hands-on in vitro pharmacology scientist to design and execute cellular assays that characterize DAC activity and degradation. The role involves building assay cascades from primary screening through mechanistic pharmacological characterization and coordinating with discovery biology, conjugation chemistry, and automation teams.

The successful candidate will design, execute, and analyze mammalian cell-based assays, work with antibody binding and intracellular drug

Qualifications

  • Ph.D. in a relevant scientific field with strong academic record or MS with 6+ years industry experience.
  • Experience designing and setting up in vitro pharmacology studies and screening cascades.
  • Hands-on mammalian cell culture and quantitative cellular assay execution and reporting.
  • Familiarity with mechanistic assays and automation workflows.

Responsibilities

  • Design, build, and optimize in vitro pharmacology assay cascades for DACs and biologics.
  • Develop and perform cell-based assays to characterize DAC activity and degradation.
  • Maintain mammalian cell lines and execute quantitative assays independently.
  • Collaborate across discovery biology, chemistry, and DMPK to advance candidates.
  • Present results and stay current with ADC/DAC literature and trends.

Skills

In vitro pharmacology
Mammalian cell culture
Assay development
Data analysis
Automation/liquid handling
Team collaboration

Education

Ph.D. in Biochemistry/Pharmacology/Biology
MS with 6+ years industry experience

Tools

Automation equipment
Luminescence assays
Cell culture facilities

Job description

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease.

Position

We are growing our DAC research team with a hands‑on in vitro screening and pharmacology scientist who will help build and shape the screening and pharmacological characterisation capability for Degrader Antibody Conjugates (DACs). Our DAC platform pairs antibody‑based targeting with our degrader expertise to direct protein degradation to specific cell types, and this scientist will play a central role in defining how candidate molecules move through the in vitro assay cascade - from primary screening through mechanistic pharmacological characterisation.

This is a lab‑based role for someone who wants to bring their own expertise in designing and running in vitro pharmacology studies into an established, highly collaborative discovery organisation. The scientist will design, execute, and analyse cellular assays that characterise DAC activity, and will partner closely with discovery biology, conjugation chemistry, analytical biochemistry, DMPK, and automation to advance candidates from early screening. The ideal candidate will be self‑driven, resourceful, and organised, and will enjoy shaping assay strategy in a dynamic team environment.

Responsibilities
  • Design, build, and optimize the in vitro pharmacology assay cascade for DACs and biologics, from primary screening through mechanistic and quantitative characterization.
  • Develop and perform cell‑based assays to characterize DAC and biologic activity, including antigen binding, target engagement, and targeted protein degradation, using cutting‑edge technologies and automated workflows.
  • Cultivate and maintain mammalian cell lines (experience manipulating cell surface antigens and engineering reporter lines used to characterize DACs is preferred).
  • Collaborate with team members to contribute to the design and execution of pharmacology studies to assess the biological activity and mechanism of action of lead molecules and drug candidates.
  • Stay current with the latest scientific literature and industry developments in the fields of ADCs, DACs, biologics, and targeted protein degradation.
  • Analyze, interpret, and clearly communicate results; present findings at internal meetings and contribute to scientific discussions that drive project advancement.
Qualifications
  • Ph.D. in a relevant scientific field (Biochemistry, Pharmacology, Biology, etc.) with a strong academic track record, or MS with 6 or more years of relevant industry experience.
  • Demonstrated experience designing and setting up in vitro pharmacology studies and screening cascades; prior know‑how in building screening/assay cascades in the ADC or DAC field is preferred.
  • Hands‑on experience with mammalian cell culture and the ability to independently execute, analyze, and report results of quantitative cellular assays relevant to conjugate characterization (e.g., luminescence‑based degradation, viability, or internalization assays).
  • Experience with mechanistic assays that dissect DAC activity, such as antibody binding and intracellular drug release, is highly desired.
  • Familiarity with automation equipment (e.g., liquid handlers) and automated workflows.
  • Strong analytical and problem‑solving skills, with sound judgement in evaluating and interpreting experimental
Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results‑oriented focus
  • Hands‑on approach; resourceful and open to diverse points of view

Salary Range: $127K - 143K

Location: Brisbane, CA (Onsite role)

Nurix Therapeutics, Inc. is committed to protecting and respecting your privacy and personal information, including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix. By applying for a position at Nurix, you agree to our collection and use of personal information as described in our Privacy Policy (https://www.nurixtx.com/privacy-policy/).

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 180,000 - 240,000
Scientist II, Degrader Antibody Conjugate Characterization Brisbane, CA
Scientist II, Degrader Antibody Conjugate Characterization Brisbane, CA

Nurix, Inc. • California (MO)

On-site
USD 140,000 - 161,000
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology

NURIX • San Francisco (CA)

On-site
USD 180,000 - 250,000
Scientist I, Bioanalytical – Drug Antibody Conjugates (DACs)
Scientist I, Bioanalytical – Drug Antibody Conjugates (DACs)

BioSpace • Brisbane (CA)

On-site
USD 124,000 - 143,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs) Brisbane, California
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs) Brisbane, California

Nurix, Inc. • California (MO)

On-site
USD 130,000 - 170,000
Scientist I, Bioanalytical – Drug Antibody Conjugates (DACs)
Scientist I, Bioanalytical – Drug Antibody Conjugates (DACs)

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 124,000 - 143,000
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs)
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs)

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 130,000 - 180,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

BioSpace • Brisbane (CA)

On-site
USD 140,000 - 161,000